Mesenchymal stromal cells (MSCs) are of therapeutic interest due to their
immunomodulatory and regenerative properties. As a therapeutic, MSCs have limitations …

The safety and efficacy of mesenchymal stem cells/marrow stromal cells (MSC) have been
widely studied. Since they are hypoimmunogenic, MSC can escape immune recognition …

Extracellular vesicles (EVs) derived from mesenchymal stromal cells (MSC-EVs) have been
proposed as a novel therapeutic tool with numerous clinically related advantages. However …

Mesenchymal stem cells (MSCs) have been revealed to hold great potential for the
development of new treatment approaches for various diseases. However, the clinical use of …

Background Extracellular vesicles (EVs) represent a new axis of intercellular communication
that can be explored for therapeutic purposes; they have garnered considerable attention for …

Extracellular vesicles (EVs) derived from mesenchymal stromal cells (MSCs) may deliver
therapeutic effects that are comparable to their parental cells. MSC-EVs are promising …

Mesenchymal stromal cells (MSCs) are multipotent cells obtained from many tissues
including bone marrow, adipose tissue, umbilical cord, amniotic fluid, and placenta. MSCs …

Background aims Umbilical cord (UC) tissue is recognized as an advantageous source of
mesenchymal stromal cells (MSCs), whose therapeutic properties are being actively …

Background Mesenchymal stromal cells (MSC) are of clinical interest for their potential use
in regenerative medicine and immunotherapy. Originally derived from bone marrow (BM) …

Mesenchymal stromal cells (MSCs) have been reported to display efficacy in a variety of
preclinical models, but without long-term engraftment, suggesting a role for secreted factors …